Yosuke Tamura

Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors

Noboru Yamamoto, Hiroshi Nokihara, Yasuhide Yamada et al. · Investigational New Drugs · 2016 · 92 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors

Shinji Nakamichi, Hiroshi Nokihara, Noboru Yamamoto et al. · Cancer Chemotherapy and Pharmacology · 2015 · 56 citations · Full text

Medicine, Oncology, Pharmacology +17

Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma

Yosuke Tamura, Yutaka Fujiwara, Noboru Yamamoto et al. · BMC Research Notes · 2015 · 54 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Effect of Minor Elements on Grain Size of Mg-9%Al Alloy

Yosuke Tamura, Tetsuichi Motegi, Norio Kôno et al. · Materials science forum · 2000 · 40 citations · Full text

Natural Sciences, Materials Engineering, Materials Science +17

Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study

Hajime Asahina, Hiroshi Nokihara, Noboru Yamamoto et al. · Investigational New Drugs · 2012 · 37 citations

Medicine, Oncology, Pharmacology +7